细菌性中风相关肺炎:微生物学分析和死亡率结果
Alshaimaa M Aboulfotooh1, Heba Sherif Abdel Aziz2, Marwa M Zein3
1Department of Neurology, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
BMC neurology
|July 30, 2024
概括
与中风相关的肺炎 (SAP) 影响三分之一的急性缺血性中风患者,增加死亡率. 关键预测因素包括气柱功能障碍,机械通风和之前的TIA/中风史.
科学领域:
- 神经学 神经学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 与中风相关的肺炎 (SAP) 造成了严重的医疗负担.
- 在急性缺血性中风 (AIS) 患者中识别SAP预测因子对于管理至关重要.
研究的目的:
- 为了确定AIS患者SAP发展的预测因素.
- 调查SAP的微生物学原因和30天死亡率的影响.
主要方法:
- 在马尼亚特种医院中风病房 (Manial Specialized Hospital Stroke Unit) 住院的AIS患者的回顾性队列研究 (2021年2月 - 2023年8月).
- 患者被分为SAP和非SAP组.
- 分析了临床数据和微生物学结果.
主要成果:
- 在522名AIS患者中,32.4%患有SAP.
- 克莱布西拉肺炎 (40.2%) 和 Pseudomonas aeruginosa (20.7%) 是常见的病原体.
- 气泡功能障碍 (OR=200.46),机械通风 (OR=4.88) 和之前的TIA/中风 (OR=3.01) 独立预测了SAP.
- 所有11例死亡都发生在SAP组中 (P < 0.001).
结论:
- 在AIS患者中,SAP显著增加了死亡率.
- 气囊功能障碍,机械通风和之前的TIA/中风是SAP的关键预测因素.
- 针对高风险患者的有针对性的关注对于降低SAP相关死亡率至关重要.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
11.7K
相关概念视频
Pneumonia III: Complications and Assessment
194
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
194
Pneumonia I: Introduction
217
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
217
Pneumonia IV: Management
315
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
315
